|132.56|| -4.25 / -3.11%|
Henry Schein, Inc. provides health care products and services to medical, dental, and veterinary office-based practitioners. It operates its business through two reportable segments: Healthcare Distribution and Technology, and Value-Added Services. The Healthcare Distribution segment aggregates its dental, medical, animal health and international operating segments. This segment consists of consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment provides software, technology and other value-added services to healthcare practitioners. It also offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services, plus continuing education services for practitioners, and continuing education services for practitioners. Henry Schein was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
|Stanley M. Bergman||Chairman & Chief Executive Officer|
|James P. Breslawski||President & Director|
|Steven Paladino||Chief Financial Officer, Director & Executive VP|
|James A. Harding||Chief Technology Officer & Senior Vice President|
|Leonard A. David||Chief Compliance Officer & Senior Vice President|